112 related articles for article (PubMed ID: 38053374)
1. RASSF1A promotes radiosensitivity in nasopharyngeal carcinoma by promoting FoxO3a and inhibiting the Nrf2/TXNRD1 signaling pathway.
Si Y; Meng L; Zhang B; Wu Y; Du Q; Xu J; Qi J
Neoplasma; 2023 Oct; 70(5):633-644. PubMed ID: 38053374
[TBL] [Abstract][Full Text] [Related]
2. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.
Huang W; Shi G; Yong Z; Li J; Qiu J; Cao Y; Zhao Y; Yuan L
Cell Death Dis; 2020 Jul; 11(7):504. PubMed ID: 32632129
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway.
Zhuang Q; Liu G; Huang W; He Z
J Radiat Res; 2023 May; 64(3):509-519. PubMed ID: 36947579
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer.
Delgobo M; Gonçalves RM; Delazeri MA; Falchetti M; Zandoná A; Nascimento das Neves R; Almeida K; Fagundes AC; Gelain DP; Fracasso JI; Macêdo GB; Priori L; Bassani N; Bishop AJR; Forcelini CM; Moreira JCF; Zanotto-Filho A
Free Radic Biol Med; 2021 Dec; 177():58-71. PubMed ID: 34673143
[TBL] [Abstract][Full Text] [Related]
6. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
[TBL] [Abstract][Full Text] [Related]
7. [Expression patterns and prognostic values of Nrf2 and Keap1 in nasopharyngeal carcinoma].
Ma XK; Liu JS
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):678-682. PubMed ID: 29771085
[No Abstract] [Full Text] [Related]
8. RASSF1A inhibits PDGFB-driven malignant phenotypes of nasopharyngeal carcinoma cells in a YAP1-dependent manner.
Liang YY; Deng XB; Lin XT; Jiang LL; Huang XT; Mo ZW; Yuan YW; Teh MT
Cell Death Dis; 2020 Oct; 11(10):855. PubMed ID: 33057010
[TBL] [Abstract][Full Text] [Related]
9. FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway.
Luo M; Wu C; Guo E; Peng S; Zhang L; Sun W; Liu D; Hu G; Hu G
Cancer Lett; 2019 Jul; 455():26-35. PubMed ID: 31022422
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway.
Wang Z; Mao JW; Liu GY; Wang FG; Ju ZS; Zhou D; Wang RY
Cancer Med; 2019 Feb; 8(2):712-728. PubMed ID: 30656832
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation.
Zhang G; Wang W; Yao C; Ren J; Zhang S; Han M
Biomed Pharmacother; 2017 Jul; 91():147-154. PubMed ID: 28453992
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.
Liu F; Tang L; Liu H; Chen Y; Xiao T; Gu W; Yang H; Wang H; Chen P
Cell Death Dis; 2024 Apr; 15(4):279. PubMed ID: 38637504
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma.
Wu LZ; Huang ML; Qi CL; Shen LJ; Zou Y; Yang R; Sheng JF; Chen SM
Bioengineered; 2021 Dec; 12(1):3398-3409. PubMed ID: 34224316
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
Ye M; Huang T; Ni C; Yang P; Chen S
EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
[TBL] [Abstract][Full Text] [Related]
15. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Zhang P; Shao Y; Quan F; Liu L; Yang J
Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 13 promotes radiotherapy sensitivity of nasopharyngeal carcinoma by downregulating the MEK/ERK pathway.
Shi M; Wan J; Wang H; Yu H
IUBMB Life; 2022 Jun; 74(6):543-553. PubMed ID: 35426961
[TBL] [Abstract][Full Text] [Related]
17. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway.
Chen E; Huang J; Chen M; Wu J; Ouyang P; Wang X; Shi D; Liu Z; Zhu W; Sun H; Yang S; Zhang B; Deng W; Qiu H; Xie F
J Transl Med; 2023 Feb; 21(1):134. PubMed ID: 36814284
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells.
Shen ED; Zeng Q
Kaohsiung J Med Sci; 2019 Aug; 35(8):474-485. PubMed ID: 31271505
[TBL] [Abstract][Full Text] [Related]
19. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
[TBL] [Abstract][Full Text] [Related]
20. AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma.
Liu X; Hu Z; Qu J; Li J; Gong K; Wang L; Jiang J; Li X; He R; Duan L; Luo W; Xia C; Luo D
Int J Biol Sci; 2021; 17(3):756-767. PubMed ID: 33767586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
